nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP2C9—Bexarotene—hematologic cancer	0.0228	0.0368	CbGbCtD
Triazolam—CYP3A7—Ifosfamide—hematologic cancer	0.0213	0.0344	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0213	0.0344	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0203	0.0328	CbGbCtD
Triazolam—CYP3A7—Imatinib—hematologic cancer	0.0203	0.0328	CbGbCtD
Triazolam—CYP2C8—Bortezomib—hematologic cancer	0.02	0.0323	CbGbCtD
Triazolam—CYP3A5—Daunorubicin—hematologic cancer	0.0199	0.0322	CbGbCtD
Triazolam—CYP2C9—Idarubicin—hematologic cancer	0.0189	0.0305	CbGbCtD
Triazolam—CYP3A5—Thalidomide—hematologic cancer	0.0181	0.0293	CbGbCtD
Triazolam—CYP3A5—Teniposide—hematologic cancer	0.0173	0.0279	CbGbCtD
Triazolam—CYP3A5—Ifosfamide—hematologic cancer	0.016	0.0258	CbGbCtD
Triazolam—CYP2C8—Ifosfamide—hematologic cancer	0.0153	0.0248	CbGbCtD
Triazolam—CYP3A5—Imatinib—hematologic cancer	0.0152	0.0246	CbGbCtD
Triazolam—CYP2C9—Bortezomib—hematologic cancer	0.014	0.0226	CbGbCtD
Triazolam—CYP2C8—Nilotinib—hematologic cancer	0.0133	0.0215	CbGbCtD
Triazolam—CYP3A4—Bexarotene—hematologic cancer	0.0132	0.0214	CbGbCtD
Triazolam—CYP3A7—Irinotecan—hematologic cancer	0.0127	0.0205	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.0127	0.0205	CbGbCtD
Triazolam—CYP3A4—Lomustine—hematologic cancer	0.0123	0.0199	CbGbCtD
Triazolam—CYP3A4—Busulfan—hematologic cancer	0.0123	0.0199	CbGbCtD
Triazolam—CYP3A5—Dasatinib—hematologic cancer	0.0122	0.0198	CbGbCtD
Triazolam—CYP2C9—Thalidomide—hematologic cancer	0.0122	0.0196	CbGbCtD
Triazolam—CYP2C9—Teniposide—hematologic cancer	0.0116	0.0187	CbGbCtD
Triazolam—CYP3A7—Vincristine—hematologic cancer	0.0111	0.0179	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.0111	0.0179	CbGbCtD
Triazolam—CYP3A4—Thiotepa—hematologic cancer	0.011	0.0177	CbGbCtD
Triazolam—CYP2C9—Ifosfamide—hematologic cancer	0.0107	0.0173	CbGbCtD
Triazolam—CYP2C9—Imatinib—hematologic cancer	0.0102	0.0165	CbGbCtD
Triazolam—CYP3A5—Irinotecan—hematologic cancer	0.00952	0.0154	CbGbCtD
Triazolam—CYP2C9—Nilotinib—hematologic cancer	0.00929	0.015	CbGbCtD
Triazolam—CYP3A4—Methoxsalen—hematologic cancer	0.00853	0.0138	CbGbCtD
Triazolam—CYP3A7—Dexamethasone—hematologic cancer	0.00836	0.0135	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00836	0.0135	CbGbCtD
Triazolam—CYP3A5—Vincristine—hematologic cancer	0.00832	0.0135	CbGbCtD
Triazolam—CYP3A4—Bortezomib—hematologic cancer	0.00811	0.0131	CbGbCtD
Triazolam—CYP3A4—Daunorubicin—hematologic cancer	0.00776	0.0125	CbGbCtD
Triazolam—CYP3A5—Etoposide—hematologic cancer	0.00763	0.0123	CbGbCtD
Triazolam—CYP2C8—Etoposide—hematologic cancer	0.00733	0.0119	CbGbCtD
Triazolam—CYP3A4—Cytarabine—hematologic cancer	0.00684	0.0111	CbGbCtD
Triazolam—CYP3A4—Teniposide—hematologic cancer	0.00674	0.0109	CbGbCtD
Triazolam—CYP3A5—Dexamethasone—hematologic cancer	0.00627	0.0101	CbGbCtD
Triazolam—CYP3A4—Ifosfamide—hematologic cancer	0.00622	0.0101	CbGbCtD
Triazolam—CYP2C8—Dexamethasone—hematologic cancer	0.00603	0.00974	CbGbCtD
Triazolam—CYP3A4—Imatinib—hematologic cancer	0.00594	0.00961	CbGbCtD
Triazolam—CYP3A4—Ruxolitinib—hematologic cancer	0.0056	0.00905	CbGbCtD
Triazolam—CYP3A4—Nilotinib—hematologic cancer	0.0054	0.00873	CbGbCtD
Triazolam—CYP3A4—Vinorelbine—hematologic cancer	0.00536	0.00866	CbGbCtD
Triazolam—CYP2C9—Cisplatin—hematologic cancer	0.00521	0.00841	CbGbCtD
Triazolam—CYP3A4—Triamcinolone—hematologic cancer	0.0049	0.00792	CbGbCtD
Triazolam—CYP3A4—Dasatinib—hematologic cancer	0.00477	0.00772	CbGbCtD
Triazolam—CYP3A4—Mitoxantrone—hematologic cancer	0.00472	0.00762	CbGbCtD
Triazolam—CYP2C9—Dexamethasone—hematologic cancer	0.0042	0.0068	CbGbCtD
Triazolam—CYP3A4—Betamethasone—hematologic cancer	0.0042	0.00679	CbGbCtD
Triazolam—CYP3A4—Prednisolone—hematologic cancer	0.00415	0.0067	CbGbCtD
Triazolam—CYP3A4—Prednisone—hematologic cancer	0.00392	0.00633	CbGbCtD
Triazolam—CYP3A4—Irinotecan—hematologic cancer	0.00371	0.006	CbGbCtD
Triazolam—CYP3A4—Vinblastine—hematologic cancer	0.0033	0.00534	CbGbCtD
Triazolam—CYP3A4—Vincristine—hematologic cancer	0.00325	0.00525	CbGbCtD
Triazolam—CYP3A4—Etoposide—hematologic cancer	0.00297	0.00481	CbGbCtD
Triazolam—CYP3A4—Dexamethasone—hematologic cancer	0.00244	0.00395	CbGbCtD
Triazolam—CYP3A4—Doxorubicin—hematologic cancer	0.00203	0.00328	CbGbCtD
Triazolam—GABRG3—testis—hematologic cancer	0.000617	0.0535	CbGeAlD
Triazolam—GABRR1—testis—hematologic cancer	0.000588	0.051	CbGeAlD
Triazolam—TSPO—hematopoietic system—hematologic cancer	0.000556	0.0482	CbGeAlD
Triazolam—GABRD—testis—hematologic cancer	0.000511	0.0443	CbGeAlD
Triazolam—GABRA5—testis—hematologic cancer	0.000475	0.0411	CbGeAlD
Triazolam—GABRP—lung—hematologic cancer	0.000453	0.0393	CbGeAlD
Triazolam—GABRR2—lymph node—hematologic cancer	0.000443	0.0384	CbGeAlD
Triazolam—GABRA3—testis—hematologic cancer	0.000442	0.0383	CbGeAlD
Triazolam—TSPO—gonad—hematologic cancer	0.000423	0.0366	CbGeAlD
Triazolam—GABRB3—gonad—hematologic cancer	0.000384	0.0333	CbGeAlD
Triazolam—GABRB2—lung—hematologic cancer	0.000382	0.0331	CbGeAlD
Triazolam—CYP2C8—hematopoietic system—hematologic cancer	0.000381	0.0331	CbGeAlD
Triazolam—TSPO—blood—hematologic cancer	0.000368	0.0319	CbGeAlD
Triazolam—GABRB2—testis—hematologic cancer	0.00036	0.0312	CbGeAlD
Triazolam—TSPO—bone marrow—hematologic cancer	0.000356	0.0309	CbGeAlD
Triazolam—GABRE—lung—hematologic cancer	0.000346	0.03	CbGeAlD
Triazolam—CYP3A5—hematopoietic system—hematologic cancer	0.000344	0.0298	CbGeAlD
Triazolam—CYP2C9—hematopoietic system—hematologic cancer	0.000339	0.0294	CbGeAlD
Triazolam—GABRE—testis—hematologic cancer	0.000326	0.0283	CbGeAlD
Triazolam—TSPO—lung—hematologic cancer	0.000323	0.028	CbGeAlD
Triazolam—TSPO—testis—hematologic cancer	0.000305	0.0264	CbGeAlD
Triazolam—GABRB3—lung—hematologic cancer	0.000293	0.0254	CbGeAlD
Triazolam—GABRB3—testis—hematologic cancer	0.000277	0.024	CbGeAlD
Triazolam—CYP3A4—hematopoietic system—hematologic cancer	0.000258	0.0224	CbGeAlD
Triazolam—CYP2C8—blood—hematologic cancer	0.000253	0.0219	CbGeAlD
Triazolam—GABRA2—lymph node—hematologic cancer	0.000238	0.0207	CbGeAlD
Triazolam—GABRE—lymph node—hematologic cancer	0.000236	0.0205	CbGeAlD
Triazolam—CYP3A5—blood—hematologic cancer	0.000228	0.0198	CbGeAlD
Triazolam—CYP2C9—blood—hematologic cancer	0.000224	0.0195	CbGeAlD
Triazolam—TSPO—lymph node—hematologic cancer	0.000221	0.0191	CbGeAlD
Triazolam—CYP2C8—testis—hematologic cancer	0.000209	0.0181	CbGeAlD
Triazolam—CYP3A5—lung—hematologic cancer	0.0002	0.0173	CbGeAlD
Triazolam—CYP3A4—blood—hematologic cancer	0.000171	0.0148	CbGeAlD
Triazolam—Flunitrazepam—UGT1A1—hematologic cancer	0.000108	0.33	CrCbGaD
Triazolam—Headache—Carmustine—hematologic cancer	6.93e-05	0.000232	CcSEcCtD
Triazolam—Shock—Betamethasone—hematologic cancer	6.92e-05	0.000232	CcSEcCtD
Triazolam—Shock—Dexamethasone—hematologic cancer	6.92e-05	0.000232	CcSEcCtD
Triazolam—Dyspnoea—Triamcinolone—hematologic cancer	6.91e-05	0.000232	CcSEcCtD
Triazolam—Agitation—Prednisone—hematologic cancer	6.9e-05	0.000231	CcSEcCtD
Triazolam—Dermatitis—Alitretinoin—hematologic cancer	6.9e-05	0.000231	CcSEcCtD
Triazolam—Vomiting—Ifosfamide—hematologic cancer	6.88e-05	0.000231	CcSEcCtD
Triazolam—Hypersensitivity—Cisplatin—hematologic cancer	6.88e-05	0.00023	CcSEcCtD
Triazolam—Tachycardia—Betamethasone—hematologic cancer	6.87e-05	0.00023	CcSEcCtD
Triazolam—Tachycardia—Dexamethasone—hematologic cancer	6.87e-05	0.00023	CcSEcCtD
Triazolam—Headache—Alitretinoin—hematologic cancer	6.86e-05	0.00023	CcSEcCtD
Triazolam—Diarrhoea—Gemcitabine—hematologic cancer	6.85e-05	0.000229	CcSEcCtD
Triazolam—Nausea—Thalidomide—hematologic cancer	6.84e-05	0.000229	CcSEcCtD
Triazolam—Dermatitis—Ifosfamide—hematologic cancer	6.82e-05	0.000228	CcSEcCtD
Triazolam—Hyperhidrosis—Dexamethasone—hematologic cancer	6.8e-05	0.000228	CcSEcCtD
Triazolam—Hyperhidrosis—Betamethasone—hematologic cancer	6.8e-05	0.000228	CcSEcCtD
Triazolam—Dizziness—Irinotecan—hematologic cancer	6.8e-05	0.000228	CcSEcCtD
Triazolam—Jaundice—Doxorubicin—hematologic cancer	6.78e-05	0.000227	CcSEcCtD
Triazolam—Stomatitis—Doxorubicin—hematologic cancer	6.78e-05	0.000227	CcSEcCtD
Triazolam—Malaise—Prednisone—hematologic cancer	6.77e-05	0.000227	CcSEcCtD
Triazolam—Abdominal pain—Etoposide—hematologic cancer	6.76e-05	0.000226	CcSEcCtD
Triazolam—Syncope—Prednisone—hematologic cancer	6.73e-05	0.000226	CcSEcCtD
Triazolam—Tinnitus—Methotrexate—hematologic cancer	6.72e-05	0.000225	CcSEcCtD
Triazolam—Vomiting—Vincristine—hematologic cancer	6.71e-05	0.000225	CcSEcCtD
Triazolam—Anorexia—Betamethasone—hematologic cancer	6.71e-05	0.000225	CcSEcCtD
Triazolam—Anorexia—Dexamethasone—hematologic cancer	6.71e-05	0.000225	CcSEcCtD
Triazolam—Asthenia—Cisplatin—hematologic cancer	6.7e-05	0.000224	CcSEcCtD
Triazolam—Fatigue—Triamcinolone—hematologic cancer	6.69e-05	0.000224	CcSEcCtD
Triazolam—Dermatitis—Vincristine—hematologic cancer	6.65e-05	0.000223	CcSEcCtD
Triazolam—Pain—Triamcinolone—hematologic cancer	6.63e-05	0.000222	CcSEcCtD
Triazolam—Headache—Vincristine—hematologic cancer	6.61e-05	0.000221	CcSEcCtD
Triazolam—Loss of consciousness—Prednisone—hematologic cancer	6.6e-05	0.000221	CcSEcCtD
Triazolam—Nausea—Carmustine—hematologic cancer	6.57e-05	0.00022	CcSEcCtD
Triazolam—Vomiting—Mitoxantrone—hematologic cancer	6.54e-05	0.000219	CcSEcCtD
Triazolam—Vomiting—Irinotecan—hematologic cancer	6.54e-05	0.000219	CcSEcCtD
Triazolam—Nausea—Alitretinoin—hematologic cancer	6.51e-05	0.000218	CcSEcCtD
Triazolam—Visual impairment—Epirubicin—hematologic cancer	6.5e-05	0.000218	CcSEcCtD
Triazolam—Hypertension—Prednisone—hematologic cancer	6.48e-05	0.000217	CcSEcCtD
Triazolam—Dermatitis—Irinotecan—hematologic cancer	6.48e-05	0.000217	CcSEcCtD
Triazolam—Dermatitis—Mitoxantrone—hematologic cancer	6.48e-05	0.000217	CcSEcCtD
Triazolam—Headache—Mitoxantrone—hematologic cancer	6.44e-05	0.000216	CcSEcCtD
Triazolam—Headache—Irinotecan—hematologic cancer	6.44e-05	0.000216	CcSEcCtD
Triazolam—Midazolam—SLC22A1—hematologic cancer	6.44e-05	0.198	CrCbGaD
Triazolam—Nausea—Ifosfamide—hematologic cancer	6.43e-05	0.000215	CcSEcCtD
Triazolam—Feeling abnormal—Triamcinolone—hematologic cancer	6.39e-05	0.000214	CcSEcCtD
Triazolam—Diarrhoea—Cisplatin—hematologic cancer	6.39e-05	0.000214	CcSEcCtD
Triazolam—Anxiety—Prednisone—hematologic cancer	6.37e-05	0.000213	CcSEcCtD
Triazolam—Vomiting—Gemcitabine—hematologic cancer	6.37e-05	0.000213	CcSEcCtD
Triazolam—Insomnia—Betamethasone—hematologic cancer	6.36e-05	0.000213	CcSEcCtD
Triazolam—Insomnia—Dexamethasone—hematologic cancer	6.36e-05	0.000213	CcSEcCtD
Triazolam—Paraesthesia—Betamethasone—hematologic cancer	6.32e-05	0.000212	CcSEcCtD
Triazolam—Paraesthesia—Dexamethasone—hematologic cancer	6.32e-05	0.000212	CcSEcCtD
Triazolam—Discomfort—Prednisone—hematologic cancer	6.32e-05	0.000212	CcSEcCtD
Triazolam—Dermatitis—Gemcitabine—hematologic cancer	6.31e-05	0.000211	CcSEcCtD
Triazolam—Hypersensitivity—Etoposide—hematologic cancer	6.3e-05	0.000211	CcSEcCtD
Triazolam—Tinnitus—Epirubicin—hematologic cancer	6.29e-05	0.000211	CcSEcCtD
Triazolam—Erythema—Methotrexate—hematologic cancer	6.28e-05	0.00021	CcSEcCtD
Triazolam—Headache—Gemcitabine—hematologic cancer	6.27e-05	0.00021	CcSEcCtD
Triazolam—Nausea—Vincristine—hematologic cancer	6.27e-05	0.00021	CcSEcCtD
Triazolam—Hypersensitivity—Prednisolone—hematologic cancer	6.21e-05	0.000208	CcSEcCtD
Triazolam—Dysgeusia—Methotrexate—hematologic cancer	6.15e-05	0.000206	CcSEcCtD
Triazolam—Asthenia—Etoposide—hematologic cancer	6.13e-05	0.000205	CcSEcCtD
Triazolam—Oedema—Prednisone—hematologic cancer	6.13e-05	0.000205	CcSEcCtD
Triazolam—Decreased appetite—Betamethasone—hematologic cancer	6.12e-05	0.000205	CcSEcCtD
Triazolam—Decreased appetite—Dexamethasone—hematologic cancer	6.12e-05	0.000205	CcSEcCtD
Triazolam—Nausea—Mitoxantrone—hematologic cancer	6.11e-05	0.000204	CcSEcCtD
Triazolam—Nausea—Irinotecan—hematologic cancer	6.11e-05	0.000204	CcSEcCtD
Triazolam—Fatigue—Betamethasone—hematologic cancer	6.07e-05	0.000203	CcSEcCtD
Triazolam—Fatigue—Dexamethasone—hematologic cancer	6.07e-05	0.000203	CcSEcCtD
Triazolam—Pruritus—Etoposide—hematologic cancer	6.05e-05	0.000203	CcSEcCtD
Triazolam—Shock—Prednisone—hematologic cancer	6.03e-05	0.000202	CcSEcCtD
Triazolam—Pain—Dexamethasone—hematologic cancer	6.02e-05	0.000202	CcSEcCtD
Triazolam—Pain—Betamethasone—hematologic cancer	6.02e-05	0.000202	CcSEcCtD
Triazolam—Visual impairment—Doxorubicin—hematologic cancer	6.02e-05	0.000201	CcSEcCtD
Triazolam—Tachycardia—Prednisone—hematologic cancer	5.98e-05	0.0002	CcSEcCtD
Triazolam—Nausea—Gemcitabine—hematologic cancer	5.95e-05	0.000199	CcSEcCtD
Triazolam—Vomiting—Cisplatin—hematologic cancer	5.93e-05	0.000199	CcSEcCtD
Triazolam—Hyperhidrosis—Prednisone—hematologic cancer	5.92e-05	0.000198	CcSEcCtD
Triazolam—Dermatitis—Cisplatin—hematologic cancer	5.88e-05	0.000197	CcSEcCtD
Triazolam—Erythema—Epirubicin—hematologic cancer	5.87e-05	0.000197	CcSEcCtD
Triazolam—Diarrhoea—Etoposide—hematologic cancer	5.85e-05	0.000196	CcSEcCtD
Triazolam—Anorexia—Prednisone—hematologic cancer	5.84e-05	0.000196	CcSEcCtD
Triazolam—Ill-defined disorder—Methotrexate—hematologic cancer	5.82e-05	0.000195	CcSEcCtD
Triazolam—Tinnitus—Doxorubicin—hematologic cancer	5.82e-05	0.000195	CcSEcCtD
Triazolam—Feeling abnormal—Dexamethasone—hematologic cancer	5.8e-05	0.000194	CcSEcCtD
Triazolam—Feeling abnormal—Betamethasone—hematologic cancer	5.8e-05	0.000194	CcSEcCtD
Triazolam—Flatulence—Epirubicin—hematologic cancer	5.79e-05	0.000194	CcSEcCtD
Triazolam—Tension—Epirubicin—hematologic cancer	5.76e-05	0.000193	CcSEcCtD
Triazolam—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.75e-05	0.000193	CcSEcCtD
Triazolam—Gastrointestinal pain—Betamethasone—hematologic cancer	5.75e-05	0.000193	CcSEcCtD
Triazolam—Dysgeusia—Epirubicin—hematologic cancer	5.75e-05	0.000193	CcSEcCtD
Triazolam—Hypersensitivity—Triamcinolone—hematologic cancer	5.71e-05	0.000191	CcSEcCtD
Triazolam—Nervousness—Epirubicin—hematologic cancer	5.7e-05	0.000191	CcSEcCtD
Triazolam—Malaise—Methotrexate—hematologic cancer	5.66e-05	0.00019	CcSEcCtD
Triazolam—Dizziness—Etoposide—hematologic cancer	5.65e-05	0.000189	CcSEcCtD
Triazolam—Muscle spasms—Epirubicin—hematologic cancer	5.65e-05	0.000189	CcSEcCtD
Triazolam—Dizziness—Prednisolone—hematologic cancer	5.58e-05	0.000187	CcSEcCtD
Triazolam—Asthenia—Triamcinolone—hematologic cancer	5.56e-05	0.000186	CcSEcCtD
Triazolam—Abdominal pain—Betamethasone—hematologic cancer	5.56e-05	0.000186	CcSEcCtD
Triazolam—Abdominal pain—Dexamethasone—hematologic cancer	5.56e-05	0.000186	CcSEcCtD
Triazolam—Nausea—Cisplatin—hematologic cancer	5.54e-05	0.000186	CcSEcCtD
Triazolam—Insomnia—Prednisone—hematologic cancer	5.54e-05	0.000186	CcSEcCtD
Triazolam—Paraesthesia—Prednisone—hematologic cancer	5.5e-05	0.000184	CcSEcCtD
Triazolam—Pruritus—Triamcinolone—hematologic cancer	5.49e-05	0.000184	CcSEcCtD
Triazolam—Ill-defined disorder—Epirubicin—hematologic cancer	5.45e-05	0.000182	CcSEcCtD
Triazolam—Vomiting—Etoposide—hematologic cancer	5.44e-05	0.000182	CcSEcCtD
Triazolam—Erythema—Doxorubicin—hematologic cancer	5.43e-05	0.000182	CcSEcCtD
Triazolam—Agitation—Epirubicin—hematologic cancer	5.4e-05	0.000181	CcSEcCtD
Triazolam—Dermatitis—Etoposide—hematologic cancer	5.39e-05	0.00018	CcSEcCtD
Triazolam—Headache—Etoposide—hematologic cancer	5.36e-05	0.000179	CcSEcCtD
Triazolam—Flatulence—Doxorubicin—hematologic cancer	5.35e-05	0.000179	CcSEcCtD
Triazolam—Chest pain—Methotrexate—hematologic cancer	5.34e-05	0.000179	CcSEcCtD
Triazolam—Tension—Doxorubicin—hematologic cancer	5.33e-05	0.000179	CcSEcCtD
Triazolam—Decreased appetite—Prednisone—hematologic cancer	5.33e-05	0.000178	CcSEcCtD
Triazolam—Dysgeusia—Doxorubicin—hematologic cancer	5.32e-05	0.000178	CcSEcCtD
Triazolam—Dermatitis—Prednisolone—hematologic cancer	5.31e-05	0.000178	CcSEcCtD
Triazolam—Malaise—Epirubicin—hematologic cancer	5.3e-05	0.000177	CcSEcCtD
Triazolam—Fatigue—Prednisone—hematologic cancer	5.28e-05	0.000177	CcSEcCtD
Triazolam—Headache—Prednisolone—hematologic cancer	5.28e-05	0.000177	CcSEcCtD
Triazolam—Discomfort—Methotrexate—hematologic cancer	5.28e-05	0.000177	CcSEcCtD
Triazolam—Nervousness—Doxorubicin—hematologic cancer	5.28e-05	0.000177	CcSEcCtD
Triazolam—Syncope—Epirubicin—hematologic cancer	5.27e-05	0.000176	CcSEcCtD
Triazolam—Constipation—Prednisone—hematologic cancer	5.24e-05	0.000176	CcSEcCtD
Triazolam—Muscle spasms—Doxorubicin—hematologic cancer	5.22e-05	0.000175	CcSEcCtD
Triazolam—Palpitations—Epirubicin—hematologic cancer	5.19e-05	0.000174	CcSEcCtD
Triazolam—Confusional state—Methotrexate—hematologic cancer	5.16e-05	0.000173	CcSEcCtD
Triazolam—Loss of consciousness—Epirubicin—hematologic cancer	5.16e-05	0.000173	CcSEcCtD
Triazolam—Dizziness—Triamcinolone—hematologic cancer	5.13e-05	0.000172	CcSEcCtD
Triazolam—Nausea—Etoposide—hematologic cancer	5.08e-05	0.00017	CcSEcCtD
Triazolam—Hypertension—Epirubicin—hematologic cancer	5.07e-05	0.00017	CcSEcCtD
Triazolam—Feeling abnormal—Prednisone—hematologic cancer	5.05e-05	0.000169	CcSEcCtD
Triazolam—Asthenia—Betamethasone—hematologic cancer	5.05e-05	0.000169	CcSEcCtD
Triazolam—Asthenia—Dexamethasone—hematologic cancer	5.05e-05	0.000169	CcSEcCtD
Triazolam—Ill-defined disorder—Doxorubicin—hematologic cancer	5.04e-05	0.000169	CcSEcCtD
Triazolam—Gastrointestinal pain—Prednisone—hematologic cancer	5.01e-05	0.000168	CcSEcCtD
Triazolam—Nausea—Prednisolone—hematologic cancer	5.01e-05	0.000168	CcSEcCtD
Triazolam—Chest pain—Epirubicin—hematologic cancer	5e-05	0.000167	CcSEcCtD
Triazolam—Agitation—Doxorubicin—hematologic cancer	4.99e-05	0.000167	CcSEcCtD
Triazolam—Anxiety—Epirubicin—hematologic cancer	4.98e-05	0.000167	CcSEcCtD
Triazolam—Pruritus—Betamethasone—hematologic cancer	4.98e-05	0.000167	CcSEcCtD
Triazolam—Pruritus—Dexamethasone—hematologic cancer	4.98e-05	0.000167	CcSEcCtD
Triazolam—Hyperhidrosis—Methotrexate—hematologic cancer	4.95e-05	0.000166	CcSEcCtD
Triazolam—Discomfort—Epirubicin—hematologic cancer	4.94e-05	0.000165	CcSEcCtD
Triazolam—Vomiting—Triamcinolone—hematologic cancer	4.93e-05	0.000165	CcSEcCtD
Triazolam—Malaise—Doxorubicin—hematologic cancer	4.9e-05	0.000164	CcSEcCtD
Triazolam—Dry mouth—Epirubicin—hematologic cancer	4.89e-05	0.000164	CcSEcCtD
Triazolam—Dermatitis—Triamcinolone—hematologic cancer	4.89e-05	0.000164	CcSEcCtD
Triazolam—Anorexia—Methotrexate—hematologic cancer	4.88e-05	0.000164	CcSEcCtD
Triazolam—Syncope—Doxorubicin—hematologic cancer	4.87e-05	0.000163	CcSEcCtD
Triazolam—Headache—Triamcinolone—hematologic cancer	4.86e-05	0.000163	CcSEcCtD
Triazolam—Abdominal pain—Prednisone—hematologic cancer	4.84e-05	0.000162	CcSEcCtD
Triazolam—Confusional state—Epirubicin—hematologic cancer	4.83e-05	0.000162	CcSEcCtD
Triazolam—Diarrhoea—Dexamethasone—hematologic cancer	4.81e-05	0.000161	CcSEcCtD
Triazolam—Diarrhoea—Betamethasone—hematologic cancer	4.81e-05	0.000161	CcSEcCtD
Triazolam—Palpitations—Doxorubicin—hematologic cancer	4.8e-05	0.000161	CcSEcCtD
Triazolam—Oedema—Epirubicin—hematologic cancer	4.79e-05	0.000161	CcSEcCtD
Triazolam—Loss of consciousness—Doxorubicin—hematologic cancer	4.78e-05	0.00016	CcSEcCtD
Triazolam—Shock—Epirubicin—hematologic cancer	4.72e-05	0.000158	CcSEcCtD
Triazolam—Hypertension—Doxorubicin—hematologic cancer	4.69e-05	0.000157	CcSEcCtD
Triazolam—Tachycardia—Epirubicin—hematologic cancer	4.68e-05	0.000157	CcSEcCtD
Triazolam—Dizziness—Betamethasone—hematologic cancer	4.65e-05	0.000156	CcSEcCtD
Triazolam—Dizziness—Dexamethasone—hematologic cancer	4.65e-05	0.000156	CcSEcCtD
Triazolam—Hyperhidrosis—Epirubicin—hematologic cancer	4.63e-05	0.000155	CcSEcCtD
Triazolam—Insomnia—Methotrexate—hematologic cancer	4.63e-05	0.000155	CcSEcCtD
Triazolam—Chest pain—Doxorubicin—hematologic cancer	4.63e-05	0.000155	CcSEcCtD
Triazolam—Anxiety—Doxorubicin—hematologic cancer	4.61e-05	0.000154	CcSEcCtD
Triazolam—Nausea—Triamcinolone—hematologic cancer	4.61e-05	0.000154	CcSEcCtD
Triazolam—Paraesthesia—Methotrexate—hematologic cancer	4.6e-05	0.000154	CcSEcCtD
Triazolam—Discomfort—Doxorubicin—hematologic cancer	4.57e-05	0.000153	CcSEcCtD
Triazolam—Anorexia—Epirubicin—hematologic cancer	4.57e-05	0.000153	CcSEcCtD
Triazolam—Dyspnoea—Methotrexate—hematologic cancer	4.57e-05	0.000153	CcSEcCtD
Triazolam—Somnolence—Methotrexate—hematologic cancer	4.55e-05	0.000152	CcSEcCtD
Triazolam—Dry mouth—Doxorubicin—hematologic cancer	4.52e-05	0.000152	CcSEcCtD
Triazolam—Hypersensitivity—Prednisone—hematologic cancer	4.52e-05	0.000151	CcSEcCtD
Triazolam—Vomiting—Dexamethasone—hematologic cancer	4.47e-05	0.00015	CcSEcCtD
Triazolam—Vomiting—Betamethasone—hematologic cancer	4.47e-05	0.00015	CcSEcCtD
Triazolam—Confusional state—Doxorubicin—hematologic cancer	4.47e-05	0.00015	CcSEcCtD
Triazolam—Decreased appetite—Methotrexate—hematologic cancer	4.45e-05	0.000149	CcSEcCtD
Triazolam—Oedema—Doxorubicin—hematologic cancer	4.43e-05	0.000149	CcSEcCtD
Triazolam—Dermatitis—Dexamethasone—hematologic cancer	4.43e-05	0.000148	CcSEcCtD
Triazolam—Dermatitis—Betamethasone—hematologic cancer	4.43e-05	0.000148	CcSEcCtD
Triazolam—Fatigue—Methotrexate—hematologic cancer	4.42e-05	0.000148	CcSEcCtD
Triazolam—Headache—Dexamethasone—hematologic cancer	4.41e-05	0.000148	CcSEcCtD
Triazolam—Headache—Betamethasone—hematologic cancer	4.41e-05	0.000148	CcSEcCtD
Triazolam—Asthenia—Prednisone—hematologic cancer	4.4e-05	0.000147	CcSEcCtD
Triazolam—Pain—Methotrexate—hematologic cancer	4.38e-05	0.000147	CcSEcCtD
Triazolam—Shock—Doxorubicin—hematologic cancer	4.36e-05	0.000146	CcSEcCtD
Triazolam—Pruritus—Prednisone—hematologic cancer	4.34e-05	0.000145	CcSEcCtD
Triazolam—Insomnia—Epirubicin—hematologic cancer	4.33e-05	0.000145	CcSEcCtD
Triazolam—Tachycardia—Doxorubicin—hematologic cancer	4.33e-05	0.000145	CcSEcCtD
Triazolam—Paraesthesia—Epirubicin—hematologic cancer	4.3e-05	0.000144	CcSEcCtD
Triazolam—Hyperhidrosis—Doxorubicin—hematologic cancer	4.29e-05	0.000144	CcSEcCtD
Triazolam—Dyspnoea—Epirubicin—hematologic cancer	4.27e-05	0.000143	CcSEcCtD
Triazolam—Somnolence—Epirubicin—hematologic cancer	4.26e-05	0.000143	CcSEcCtD
Triazolam—Anorexia—Doxorubicin—hematologic cancer	4.23e-05	0.000142	CcSEcCtD
Triazolam—Feeling abnormal—Methotrexate—hematologic cancer	4.22e-05	0.000141	CcSEcCtD
Triazolam—Diarrhoea—Prednisone—hematologic cancer	4.19e-05	0.00014	CcSEcCtD
Triazolam—Gastrointestinal pain—Methotrexate—hematologic cancer	4.19e-05	0.00014	CcSEcCtD
Triazolam—Nausea—Dexamethasone—hematologic cancer	4.18e-05	0.00014	CcSEcCtD
Triazolam—Nausea—Betamethasone—hematologic cancer	4.18e-05	0.00014	CcSEcCtD
Triazolam—Decreased appetite—Epirubicin—hematologic cancer	4.17e-05	0.00014	CcSEcCtD
Triazolam—Fatigue—Epirubicin—hematologic cancer	4.13e-05	0.000138	CcSEcCtD
Triazolam—Constipation—Epirubicin—hematologic cancer	4.1e-05	0.000137	CcSEcCtD
Triazolam—Pain—Epirubicin—hematologic cancer	4.1e-05	0.000137	CcSEcCtD
Triazolam—Dizziness—Prednisone—hematologic cancer	4.05e-05	0.000136	CcSEcCtD
Triazolam—Abdominal pain—Methotrexate—hematologic cancer	4.05e-05	0.000136	CcSEcCtD
Triazolam—Insomnia—Doxorubicin—hematologic cancer	4.01e-05	0.000134	CcSEcCtD
Triazolam—Paraesthesia—Doxorubicin—hematologic cancer	3.98e-05	0.000133	CcSEcCtD
Triazolam—Dyspnoea—Doxorubicin—hematologic cancer	3.95e-05	0.000132	CcSEcCtD
Triazolam—Feeling abnormal—Epirubicin—hematologic cancer	3.95e-05	0.000132	CcSEcCtD
Triazolam—Somnolence—Doxorubicin—hematologic cancer	3.94e-05	0.000132	CcSEcCtD
Triazolam—Gastrointestinal pain—Epirubicin—hematologic cancer	3.92e-05	0.000131	CcSEcCtD
Triazolam—Vomiting—Prednisone—hematologic cancer	3.9e-05	0.00013	CcSEcCtD
Triazolam—Dermatitis—Prednisone—hematologic cancer	3.86e-05	0.000129	CcSEcCtD
Triazolam—Decreased appetite—Doxorubicin—hematologic cancer	3.86e-05	0.000129	CcSEcCtD
Triazolam—Headache—Prednisone—hematologic cancer	3.84e-05	0.000129	CcSEcCtD
Triazolam—Fatigue—Doxorubicin—hematologic cancer	3.82e-05	0.000128	CcSEcCtD
Triazolam—Pain—Doxorubicin—hematologic cancer	3.79e-05	0.000127	CcSEcCtD
Triazolam—Constipation—Doxorubicin—hematologic cancer	3.79e-05	0.000127	CcSEcCtD
Triazolam—Abdominal pain—Epirubicin—hematologic cancer	3.79e-05	0.000127	CcSEcCtD
Triazolam—Hypersensitivity—Methotrexate—hematologic cancer	3.77e-05	0.000126	CcSEcCtD
Triazolam—Asthenia—Methotrexate—hematologic cancer	3.67e-05	0.000123	CcSEcCtD
Triazolam—Feeling abnormal—Doxorubicin—hematologic cancer	3.65e-05	0.000122	CcSEcCtD
Triazolam—Nausea—Prednisone—hematologic cancer	3.64e-05	0.000122	CcSEcCtD
Triazolam—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.63e-05	0.000121	CcSEcCtD
Triazolam—Pruritus—Methotrexate—hematologic cancer	3.62e-05	0.000121	CcSEcCtD
Triazolam—Hypersensitivity—Epirubicin—hematologic cancer	3.53e-05	0.000118	CcSEcCtD
Triazolam—Abdominal pain—Doxorubicin—hematologic cancer	3.51e-05	0.000117	CcSEcCtD
Triazolam—Diarrhoea—Methotrexate—hematologic cancer	3.5e-05	0.000117	CcSEcCtD
Triazolam—Asthenia—Epirubicin—hematologic cancer	3.44e-05	0.000115	CcSEcCtD
Triazolam—Pruritus—Epirubicin—hematologic cancer	3.39e-05	0.000114	CcSEcCtD
Triazolam—Dizziness—Methotrexate—hematologic cancer	3.39e-05	0.000113	CcSEcCtD
Triazolam—Clonazepam—ALB—hematologic cancer	3.28e-05	0.101	CrCbGaD
Triazolam—Diarrhoea—Epirubicin—hematologic cancer	3.28e-05	0.00011	CcSEcCtD
Triazolam—Hypersensitivity—Doxorubicin—hematologic cancer	3.27e-05	0.000109	CcSEcCtD
Triazolam—Vomiting—Methotrexate—hematologic cancer	3.26e-05	0.000109	CcSEcCtD
Triazolam—Dermatitis—Methotrexate—hematologic cancer	3.23e-05	0.000108	CcSEcCtD
Triazolam—Headache—Methotrexate—hematologic cancer	3.21e-05	0.000107	CcSEcCtD
Triazolam—Asthenia—Doxorubicin—hematologic cancer	3.18e-05	0.000107	CcSEcCtD
Triazolam—Dizziness—Epirubicin—hematologic cancer	3.17e-05	0.000106	CcSEcCtD
Triazolam—Pruritus—Doxorubicin—hematologic cancer	3.14e-05	0.000105	CcSEcCtD
Triazolam—Vomiting—Epirubicin—hematologic cancer	3.05e-05	0.000102	CcSEcCtD
Triazolam—Nausea—Methotrexate—hematologic cancer	3.04e-05	0.000102	CcSEcCtD
Triazolam—Diarrhoea—Doxorubicin—hematologic cancer	3.03e-05	0.000102	CcSEcCtD
Triazolam—Dermatitis—Epirubicin—hematologic cancer	3.02e-05	0.000101	CcSEcCtD
Triazolam—Headache—Epirubicin—hematologic cancer	3e-05	0.000101	CcSEcCtD
Triazolam—Dizziness—Doxorubicin—hematologic cancer	2.93e-05	9.82e-05	CcSEcCtD
Triazolam—Nausea—Epirubicin—hematologic cancer	2.85e-05	9.53e-05	CcSEcCtD
Triazolam—Vomiting—Doxorubicin—hematologic cancer	2.82e-05	9.44e-05	CcSEcCtD
Triazolam—Dermatitis—Doxorubicin—hematologic cancer	2.79e-05	9.36e-05	CcSEcCtD
Triazolam—Headache—Doxorubicin—hematologic cancer	2.78e-05	9.3e-05	CcSEcCtD
Triazolam—Clobazam—ABCB1—hematologic cancer	2.75e-05	0.0844	CrCbGaD
Triazolam—Nausea—Doxorubicin—hematologic cancer	2.63e-05	8.82e-05	CcSEcCtD
Triazolam—Chlorprothixene—ABCB1—hematologic cancer	2.16e-05	0.0664	CrCbGaD
Triazolam—Flurazepam—ABCB1—hematologic cancer	2.02e-05	0.062	CrCbGaD
Triazolam—Midazolam—ABCB1—hematologic cancer	1.87e-05	0.0575	CrCbGaD
Triazolam—Diazepam—ALB—hematologic cancer	1.68e-05	0.0516	CrCbGaD
Triazolam—Diazepam—ABCB1—hematologic cancer	1.6e-05	0.0493	CrCbGaD
Triazolam—CYP3A5—Metabolism—HMMR—hematologic cancer	1.08e-05	0.000153	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.08e-05	0.000152	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ADCY7—hematologic cancer	1.07e-05	0.00015	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NCOA3—hematologic cancer	1.07e-05	0.00015	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NUP214—hematologic cancer	1.06e-05	0.000149	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—HRAS—hematologic cancer	1.06e-05	0.000149	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PC—hematologic cancer	1.04e-05	0.000147	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—HRAS—hematologic cancer	1.04e-05	0.000147	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MTR—hematologic cancer	1.04e-05	0.000146	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ABCG2—hematologic cancer	1.04e-05	0.000146	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PHYH—hematologic cancer	1.03e-05	0.000145	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—FTCD—hematologic cancer	1.03e-05	0.000145	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GMPS—hematologic cancer	1.03e-05	0.000145	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—HRAS—hematologic cancer	1.02e-05	0.000144	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ENO2—hematologic cancer	1.02e-05	0.000143	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ARNTL—hematologic cancer	1.02e-05	0.000143	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—HRAS—hematologic cancer	1.01e-05	0.000143	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—FHL2—hematologic cancer	1.01e-05	0.000142	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC35B2—hematologic cancer	1.01e-05	0.000142	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GBA—hematologic cancer	1.01e-05	0.000142	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1e-05	0.000142	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—HRAS—hematologic cancer	9.97e-06	0.000141	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ACP5—hematologic cancer	9.9e-06	0.00014	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CA9—hematologic cancer	9.9e-06	0.00014	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AGRN—hematologic cancer	9.89e-06	0.000139	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTT1—hematologic cancer	9.87e-06	0.000139	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NCOR2—hematologic cancer	9.77e-06	0.000138	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SDC1—hematologic cancer	9.65e-06	0.000136	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SMPD3—hematologic cancer	9.42e-06	0.000133	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	9.41e-06	0.000133	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—IDH2—hematologic cancer	9.37e-06	0.000132	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HMMR—hematologic cancer	9.37e-06	0.000132	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—IDH1—hematologic cancer	9.3e-06	0.000131	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MTAP—hematologic cancer	9.21e-06	0.00013	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCC3—hematologic cancer	9.2e-06	0.00013	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTO1—hematologic cancer	9.2e-06	0.00013	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TXN—hematologic cancer	9.2e-06	0.00013	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SPHK1—hematologic cancer	9e-06	0.000127	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.84e-06	0.000125	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ARNTL—hematologic cancer	8.81e-06	0.000124	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—HRAS—hematologic cancer	8.71e-06	0.000123	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—UGT1A1—hematologic cancer	8.65e-06	0.000122	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ACP5—hematologic cancer	8.57e-06	0.000121	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CA9—hematologic cancer	8.57e-06	0.000121	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NCOR2—hematologic cancer	8.46e-06	0.000119	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SLC22A1—hematologic cancer	8.41e-06	0.000119	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CRABP1—hematologic cancer	8.41e-06	0.000119	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—DCK—hematologic cancer	8.23e-06	0.000116	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—B3GAT1—hematologic cancer	8.23e-06	0.000116	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ASNS—hematologic cancer	8.23e-06	0.000116	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—FHL2—hematologic cancer	8.2e-06	0.000116	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NQO1—hematologic cancer	8.2e-06	0.000116	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CD44—hematologic cancer	8.2e-06	0.000116	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALOX5—hematologic cancer	8.2e-06	0.000116	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—IDH1—hematologic cancer	8.06e-06	0.000114	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AGRN—hematologic cancer	8.05e-06	0.000113	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TXN—hematologic cancer	7.97e-06	0.000112	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCC3—hematologic cancer	7.97e-06	0.000112	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTO1—hematologic cancer	7.97e-06	0.000112	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NUP98—hematologic cancer	7.94e-06	0.000112	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HDC—hematologic cancer	7.81e-06	0.00011	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SPHK1—hematologic cancer	7.8e-06	0.00011	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYCS—hematologic cancer	7.76e-06	0.000109	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—HSP90AA1—hematologic cancer	7.71e-06	0.000109	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ADCY7—hematologic cancer	7.71e-06	0.000109	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NCOA3—hematologic cancer	7.71e-06	0.000109	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NUP214—hematologic cancer	7.66e-06	0.000108	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HMMR—hematologic cancer	7.63e-06	0.000108	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—IDH2—hematologic cancer	7.63e-06	0.000108	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MTR—hematologic cancer	7.5e-06	0.000106	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCG2—hematologic cancer	7.5e-06	0.000106	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—UGT1A1—hematologic cancer	7.49e-06	0.000106	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ENO2—hematologic cancer	7.36e-06	0.000104	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CRABP1—hematologic cancer	7.29e-06	0.000103	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC22A1—hematologic cancer	7.29e-06	0.000103	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.19e-06	0.000101	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ARNTL—hematologic cancer	7.17e-06	0.000101	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CDA—hematologic cancer	7.14e-06	0.000101	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTT1—hematologic cancer	7.13e-06	0.000101	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALOX5—hematologic cancer	7.1e-06	0.0001	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CA9—hematologic cancer	6.98e-06	9.84e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ACP5—hematologic cancer	6.98e-06	9.84e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SDC1—hematologic cancer	6.97e-06	9.83e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NCOR2—hematologic cancer	6.89e-06	9.71e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NUP98—hematologic cancer	6.88e-06	9.7e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PC—hematologic cancer	6.87e-06	9.69e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTP1—hematologic cancer	6.84e-06	9.65e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ADCY7—hematologic cancer	6.68e-06	9.42e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NCOA3—hematologic cancer	6.68e-06	9.42e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GBA—hematologic cancer	6.64e-06	9.36e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.64e-06	9.36e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NUP214—hematologic cancer	6.63e-06	9.35e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.56e-06	9.25e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—IDH1—hematologic cancer	6.56e-06	9.25e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCG2—hematologic cancer	6.5e-06	9.16e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MTR—hematologic cancer	6.5e-06	9.16e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTO1—hematologic cancer	6.49e-06	9.15e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCC3—hematologic cancer	6.49e-06	9.15e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TXN—hematologic cancer	6.49e-06	9.15e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ABCB1—hematologic cancer	6.48e-06	9.13e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ENO2—hematologic cancer	6.37e-06	8.98e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SPHK1—hematologic cancer	6.35e-06	8.95e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NCOR1—hematologic cancer	6.29e-06	8.87e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTM1—hematologic cancer	6.29e-06	8.87e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTT1—hematologic cancer	6.18e-06	8.71e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—UGT1A1—hematologic cancer	6.1e-06	8.6e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.08e-06	8.58e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTAP—hematologic cancer	6.07e-06	8.56e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SDC1—hematologic cancer	6.04e-06	8.52e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CRABP1—hematologic cancer	5.93e-06	8.37e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC22A1—hematologic cancer	5.93e-06	8.37e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NQO1—hematologic cancer	5.93e-06	8.36e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CD44—hematologic cancer	5.93e-06	8.36e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALOX5—hematologic cancer	5.78e-06	8.15e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.77e-06	8.14e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.69e-06	8.03e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYCS—hematologic cancer	5.61e-06	7.91e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NUP98—hematologic cancer	5.6e-06	7.9e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	5.57e-06	7.86e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MTHFR—hematologic cancer	5.56e-06	7.83e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.45e-06	7.68e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ADCY7—hematologic cancer	5.44e-06	7.66e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NCOA3—hematologic cancer	5.44e-06	7.66e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—FHL2—hematologic cancer	5.41e-06	7.63e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NUP214—hematologic cancer	5.4e-06	7.61e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.34e-06	7.53e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AGRN—hematologic cancer	5.31e-06	7.48e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCG2—hematologic cancer	5.29e-06	7.46e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MTR—hematologic cancer	5.29e-06	7.46e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ENO2—hematologic cancer	5.18e-06	7.31e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CD44—hematologic cancer	5.14e-06	7.24e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NQO1—hematologic cancer	5.14e-06	7.24e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HMMR—hematologic cancer	5.03e-06	7.09e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—IDH2—hematologic cancer	5.03e-06	7.09e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTT1—hematologic cancer	5.03e-06	7.09e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.03e-06	7.09e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.95e-06	6.98e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTP1—hematologic cancer	4.94e-06	6.97e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SDC1—hematologic cancer	4.92e-06	6.93e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYCS—hematologic cancer	4.86e-06	6.85e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	4.83e-06	6.81e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.73e-06	6.67e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.7e-06	6.62e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCB1—hematologic cancer	4.68e-06	6.6e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CG—hematologic cancer	4.67e-06	6.58e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.63e-06	6.54e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ACP5—hematologic cancer	4.6e-06	6.49e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CA9—hematologic cancer	4.6e-06	6.49e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTM1—hematologic cancer	4.54e-06	6.41e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NCOR1—hematologic cancer	4.54e-06	6.41e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.54e-06	6.4e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.43e-06	6.25e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.35e-06	6.13e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CREBBP—hematologic cancer	4.33e-06	6.1e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—IDH1—hematologic cancer	4.33e-06	6.1e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.28e-06	6.04e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.28e-06	6.03e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TXN—hematologic cancer	4.28e-06	6.03e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.28e-06	6.03e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.19e-06	5.9e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NQO1—hematologic cancer	4.18e-06	5.89e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CD44—hematologic cancer	4.18e-06	5.89e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.14e-06	5.84e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CD—hematologic cancer	4.1e-06	5.79e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.09e-06	5.77e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCB1—hematologic cancer	4.05e-06	5.72e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALB—hematologic cancer	4.05e-06	5.71e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.02e-06	5.67e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MTHFR—hematologic cancer	4.02e-06	5.66e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYCS—hematologic cancer	3.95e-06	5.58e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.94e-06	5.55e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.94e-06	5.55e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.93e-06	5.54e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.91e-06	5.52e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.91e-06	5.52e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3R1—hematologic cancer	3.87e-06	5.46e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.81e-06	5.38e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NUP98—hematologic cancer	3.69e-06	5.21e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.58e-06	5.05e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.58e-06	5.05e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CB—hematologic cancer	3.58e-06	5.04e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NUP214—hematologic cancer	3.56e-06	5.02e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.54e-06	4.99e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTR—hematologic cancer	3.49e-06	4.92e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.49e-06	4.92e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.49e-06	4.92e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.48e-06	4.91e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ENO2—hematologic cancer	3.42e-06	4.82e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CG—hematologic cancer	3.37e-06	4.76e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.37e-06	4.76e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.32e-06	4.68e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.3e-06	4.65e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SDC1—hematologic cancer	3.24e-06	4.57e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.2e-06	4.52e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.2e-06	4.52e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CREBBP—hematologic cancer	3.13e-06	4.41e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTEN—hematologic cancer	3.09e-06	4.36e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.07e-06	4.32e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.97e-06	4.18e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—EP300—hematologic cancer	2.95e-06	4.16e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALB—hematologic cancer	2.93e-06	4.13e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.92e-06	4.12e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.83e-06	3.99e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.8e-06	3.95e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CD44—hematologic cancer	2.76e-06	3.89e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NQO1—hematologic cancer	2.76e-06	3.89e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.71e-06	3.82e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYCS—hematologic cancer	2.61e-06	3.68e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.59e-06	3.65e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.59e-06	3.65e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.57e-06	3.62e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALB—hematologic cancer	2.54e-06	3.58e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.49e-06	3.52e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.43e-06	3.42e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.38e-06	3.35e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.3e-06	3.24e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.24e-06	3.16e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTEN—hematologic cancer	2.23e-06	3.15e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.21e-06	3.11e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CA—hematologic cancer	2.18e-06	3.07e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.18e-06	3.07e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—EP300—hematologic cancer	2.13e-06	3e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.11e-06	2.98e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.11e-06	2.98e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.09e-06	2.95e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALB—hematologic cancer	2.06e-06	2.91e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.97e-06	2.78e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTEN—hematologic cancer	1.94e-06	2.73e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.87e-06	2.63e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—EP300—hematologic cancer	1.85e-06	2.6e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.82e-06	2.57e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—AKT1—hematologic cancer	1.78e-06	2.51e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.58e-06	2.22e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTEN—hematologic cancer	1.57e-06	2.22e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.57e-06	2.21e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—EP300—hematologic cancer	1.5e-06	2.12e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.45e-06	2.05e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.38e-06	1.94e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.37e-06	1.93e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALB—hematologic cancer	1.36e-06	1.92e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.3e-06	1.84e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AKT1—hematologic cancer	1.29e-06	1.82e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.2e-06	1.7e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AKT1—hematologic cancer	1.12e-06	1.57e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.11e-06	1.57e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTEN—hematologic cancer	1.04e-06	1.46e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—EP300—hematologic cancer	9.91e-07	1.4e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AKT1—hematologic cancer	9.08e-07	1.28e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.33e-07	1.03e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AKT1—hematologic cancer	5.99e-07	8.44e-06	CbGpPWpGaD
